Sun G, Zhao C, Han J, Wu S, Chen Y, Yao J
Cell Oncol (Dordr). 2024; 47(6):2073-2090.
PMID: 39543064
DOI: 10.1007/s13402-024-01011-y.
Kang Y
Clin Transl Oncol. 2023; 25(7):1869-1892.
PMID: 37067729
PMC: 10250522.
DOI: 10.1007/s12094-023-03189-3.
Thabet R, Gomaa A, Matalqah L, Shalaby E
J Int Med Res. 2022; 50(7):3000605221113800.
PMID: 35883275
PMC: 9340350.
DOI: 10.1177/03000605221113800.
Mahmoodi A, Shoqafi A, Sun P, Giannakeas V, Cybulski C, Nofech-Mozes S
Front Oncol. 2022; 12:877617.
PMID: 35712517
PMC: 9195420.
DOI: 10.3389/fonc.2022.877617.
Bhardwaj P, Au C, Benito-Martin A, Ladumor H, Oshchepkova S, Moges R
J Steroid Biochem Mol Biol. 2019; 189:161-170.
PMID: 30851382
PMC: 6502693.
DOI: 10.1016/j.jsbmb.2019.03.002.
Systemic treatment and radiotherapy, breast cancer subtypes, and survival after long-term clinical follow-up.
Yang S, Polley E
Breast Cancer Res Treat. 2019; 175(2):287-295.
PMID: 30746635
PMC: 6533413.
DOI: 10.1007/s10549-019-05142-x.
Deciphering Steroid Receptor Crosstalk in Hormone-Driven Cancers.
Truong T, Lange C
Endocrinology. 2018; 159(12):3897-3907.
PMID: 30307542
PMC: 6236424.
DOI: 10.1210/en.2018-00831.
Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast Cancer.
Campos-Parra A, Lopez-Urrutia E, Orozco Moreno L, Lopez-Camarillo C, Meza-Menchaca T, Figueroa Gonzalez G
Int J Mol Sci. 2018; 19(9).
PMID: 30208633
PMC: 6164317.
DOI: 10.3390/ijms19092711.
Chromatin reprogramming in breast cancer.
Swinstead E, Paakinaho V, Hager G
Endocr Relat Cancer. 2018; 25(7):R385-R404.
PMID: 29692347
PMC: 6029727.
DOI: 10.1530/ERC-18-0033.
Dual Src Kinase/Pretubulin Inhibitor KX-01, Sensitizes ERα-negative Breast Cancers to Tamoxifen through ERα Reexpression.
Anbalagan M, Sheng M, Fleischer B, Zhang Y, Gao Y, Hoang V
Mol Cancer Res. 2017; 15(11):1491-1502.
PMID: 28751463
PMC: 5930017.
DOI: 10.1158/1541-7786.MCR-16-0297-T.
Ficus umbellata Vahl. (Moraceae) Stem Bark Extracts Exert Antitumor Activities In Vitro and In Vivo.
Silihe K, Zingue S, Winter E, Awounfack C, Bishayee A, Desai N
Int J Mol Sci. 2017; 18(6).
PMID: 28545243
PMC: 5485928.
DOI: 10.3390/ijms18061073.
Steroid Hormone Receptor Positive Breast Cancer Patient-Derived Xenografts.
Matthews S, Sartorius C
Horm Cancer. 2016; 8(1):4-15.
PMID: 27796944
PMC: 5291783.
DOI: 10.1007/s12672-016-0275-0.
Minireview: The Link Between ERα Corepressors and Histone Deacetylases in Tamoxifen Resistance in Breast Cancer.
Legare S, Basik M
Mol Endocrinol. 2016; 30(9):965-76.
PMID: 27581354
PMC: 5414611.
DOI: 10.1210/me.2016-1072.
Tissue-Specific Expression of Estrogen Receptor 1 Is Regulated by DNA Methylation in a T-DMR.
Maekawa R, Sato S, Okada M, Lee L, Tamura I, Jozaki K
Mol Endocrinol. 2015; 30(3):335-47.
PMID: 26683811
PMC: 5414650.
DOI: 10.1210/me.2015-1058.
Form and function: how estrogen and progesterone regulate the mammary epithelial hierarchy.
Arendt L, Kuperwasser C
J Mammary Gland Biol Neoplasia. 2015; 20(1-2):9-25.
PMID: 26188694
PMC: 4596764.
DOI: 10.1007/s10911-015-9337-0.
The methyl donor S-adenosylmethionine potentiates doxorubicin effects on apoptosis of hormone-dependent breast cancer cell lines.
Ilisso C, Castellano M, Zappavigna S, Lombardi A, Vitale G, Dicitore A
Endocrine. 2015; 50(1):212-22.
PMID: 25577236
DOI: 10.1007/s12020-014-0484-7.
Tracking progesterone receptor-mediated actions in breast cancer.
Knutson T, Lange C
Pharmacol Ther. 2013; 142(1):114-25.
PMID: 24291072
PMC: 3943696.
DOI: 10.1016/j.pharmthera.2013.11.010.
Innovations in health care and mortality trends from five cancers in seven European countries between 1970 and 2005.
Hoffmann R, Plug I, Mckee M, Khoshaba B, Westerling R, Looman C
Int J Public Health. 2013; 59(2):341-50.
PMID: 23989709
DOI: 10.1007/s00038-013-0507-9.
Quantitative hormone therapy follow-up in an ER+/ERαKD mouse tumor model using FDG and [11C]-methionine PET imaging.
Paquette M, Tremblay S, Benard F, Lecomte R
EJNMMI Res. 2012; 2(1):61.
PMID: 23140372
PMC: 3508933.
DOI: 10.1186/2191-219X-2-61.
Arsenic induces functional re-expression of estrogen receptor α by demethylation of DNA in estrogen receptor-negative human breast cancer.
Du J, Zhou N, Liu H, Jiang F, Wang Y, Hu C
PLoS One. 2012; 7(4):e35957.
PMID: 22558281
PMC: 3338760.
DOI: 10.1371/journal.pone.0035957.
